Published online 10 January 2005. doi:10.1083/jcb.200407070
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 168, Number 2, 291-302
BACE overexpression alters the subcellular processing of APP and inhibits Aß deposition in vivo
Edward B. Lee1,
Bin Zhang1,
Kangning Liu1,
Eric A. Greenbaum1,
Robert W. Doms2,
John Q. Trojanowski1,3, and
Virginia M.-Y. Lee1,3
1 The Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine
2 Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
3 Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Correspondence to Virginia M.-Y. Lee: vmylee{at}mail.med.upenn.edu
Introducing mutations within the amyloid precursor protein (APP) that affect ß- and
-secretase cleavages results in amyloid plaque formation in vivo. However, the relationship between ß-amyloid deposition and the subcellular site of Aß production is unknown. To determine the effect of increasing ß-secretase (BACE) activity on Aß deposition, we generated transgenic mice overexpressing human BACE. Although modest overexpression enhanced amyloid deposition, high BACE overexpression inhibited amyloid formation despite increased ß-cleavage of APP. However, high BACE expression shifted the subcellular location of APP cleavage to the neuronal perikarya early in the secretory pathway. These results suggest that the production, clearance, and aggregation of Aß peptides are highly dependent on the specific neuronal subcellular domain wherein Aß is generated and highlight the importance of perikaryal versus axonal APP proteolysis in the development of Aß amyloid pathology in Alzheimer's disease.
Abbreviations used in this paper: AD, Alzheimer's disease; APP, amyloid precursor protein; BACE, ß-secretase; FA, formic acid; IDE, insulin-degrading enzyme; NFM, molecular weight neurofilament subunit; PhAT, antiphospho-APP-threonine 668; PrP, prion protein; Tg, transgenic.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Moreno, H., Yu, E., Pigino, G., Hernandez, A. I., Kim, N., Moreira, J. E., Sugimori, M., Llinas, R. R.
(2009). Synaptic transmission block by presynaptic injection of oligomeric amyloid beta. Proc. Natl. Acad. Sci. USA
106: 5901-5906
[Abstract]
[Full Text]
-
Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vassar, R., Wong, P. C., Fukata, M., Kounnas, M. Z., Thinakaran, G.
(2009). Alzheimer Disease A{beta} Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts. J. Biol. Chem.
284: 3793-3803
[Abstract]
[Full Text]
-
Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., Williams, D. S., Goldstein, L. S.B.
(2008). Amyloid precursor protein-induced axonopathies are independent of amyloid-{beta} peptides. Hum Mol Genet
17: 3474-3486
[Abstract]
[Full Text]
-
Kim, M. L., Zhang, B., Mills, I. P., Milla, M. E., Brunden, K. R., Lee, V. M.-Y.
(2008). Effects of TNF{alpha}-Converting Enzyme Inhibition on Amyloid {beta} Production and APP Processing In Vitro and In Vivo. J. Neurosci.
28: 12052-12061
[Abstract]
[Full Text]
-
Muhammad, A., Flores, I., Zhang, H., Yu, R., Staniszewski, A., Planel, E., Herman, M., Ho, L., Kreber, R., Honig, L. S., Ganetzky, B., Duff, K., Arancio, O., Small, S. A.
(2008). Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and A{beta} accumulation. Proc. Natl. Acad. Sci. USA
105: 7327-7332
[Abstract]
[Full Text]
-
Shineman, D. W., Zhang, B., Leight, S. N., Pratico, D., Lee, V. M.-Y.
(2008). Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice. J. Neurosci.
28: 4785-4794
[Abstract]
[Full Text]
-
Sankaranarayanan, S., Price, E. A., Wu, G., Crouthamel, M.-C., Shi, X.-P., Tugusheva, K., Tyler, K. X., Kahana, J., Ellis, J., Jin, L., Steele, T., Stachel, S., Coburn, C., Simon, A. J.
(2008). In Vivo {beta}-Secretase 1 Inhibition Leads to Brain A{beta} Lowering and Increased {alpha}-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1. J. Pharmacol. Exp. Ther.
324: 957-969
[Abstract]
[Full Text]
-
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., Zhang, Y.-w.
(2007). Hypoxia-inducible Factor 1{alpha} (HIF-1{alpha})-mediated Hypoxia Increases BACE1 Expression and beta-Amyloid Generation. J. Biol. Chem.
282: 10873-10880
[Abstract]
[Full Text]
-
Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., Binder, L., Vassar, R.
(2007). {beta}-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis. J. Neurosci.
27: 3639-3649
[Abstract]
[Full Text]
-
Goldsbury, C., Thies, E., Konzack, S., Mandelkow, E.-M.
(2007). Quantification of Amyloid Precursor Protein and Tau for the Study of Axonal Traffic Pathways. J. Neurosci.
27: 3357-3363
[Full Text]
-
Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., Masliah, E.
(2007). Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3{beta} Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation. J. Neurosci.
27: 1981-1991
[Abstract]
[Full Text]
-
Wahle, T., Thal, D. R., Sastre, M., Rentmeister, A., Bogdanovic, N., Famulok, M., Heneka, M. T., Walter, J.
(2006). GGA1 Is Expressed in the Human Brain and Affects the Generation of Amyloid {beta}-Peptide. J. Neurosci.
26: 12838-12846
[Abstract]
[Full Text]
-
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R., Vassar, R.
(2006). Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation. J. Neurosci.
26: 10129-10140
[Abstract]
[Full Text]
-
von Arnim, C. A. F., Spoelgen, R., Peltan, I. D., Deng, M., Courchesne, S., Koker, M., Matsui, T., Kowa, H., Lichtenthaler, S. F., Irizarry, M. C., Hyman, B. T.
(2006). GGA1 Acts as a Spatial Switch Altering Amyloid Precursor Protein Trafficking and Processing. J. Neurosci.
26: 9913-9922
[Abstract]
[Full Text]
-
Muresan, Z., Muresan, V.
(2006). Neuritic Deposits of Amyloid-{beta} Peptide in a Subpopulation of Central Nervous System-Derived Neuronal Cells.. Mol. Cell. Biol.
26: 4982-4997
[Abstract]
[Full Text]
-
Lee, E. B., Leng, L. Z., Zhang, B., Kwong, L., Trojanowski, J. Q., Abel, T., Lee, V. M.-Y.
(2006). Targeting Amyloid-beta Peptide (Abeta) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Abeta Precursor Protein (APP) Transgenic Mice. J. Biol. Chem.
281: 4292-4299
[Abstract]
[Full Text]
-
Muresan, Z., Muresan, V.
(2005). Coordinated transport of phosphorylated amyloid-{beta} precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. JCB
171: 615-625
[Abstract]
[Full Text]
-
Rockenstein, E., Mante, M., Alford, M., Adame, A., Crews, L., Hashimoto, M., Esposito, L., Mucke, L., Masliah, E.
(2005). High {beta}-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-{beta} Levels: IMPLICATIONS FOR THE TREATMENT OF ALZHEIMER DISEASE. J. Biol. Chem.
280: 32957-32967
[Abstract]
[Full Text]
-
Lazarov, O., Morfini, G. A., Lee, E. B., Farah, M. H., Szodorai, A., DeBoer, S. R., Koliatsos, V. E., Kins, S., Lee, V. M.-Y., Wong, P. C., Price, D. L., Brady, S. T., Sisodia, S. S.
(2005). Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited. J. Neurosci.
25: 2386-2395
[Abstract]
[Full Text]